Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
The Calmer Co International Limited (CCO.AX)
West End, QLD, AU
The Calmer Co International Limited is a health and wellness enterprise focused on medicinal kava, conducting its operations in Australia, New Zealand, Fiji, and the United States. This company manufactures and distributes noble kava extract products, offered as both capsules and powder blends, under its well-known Fiji Kava and Taki Mai brands. Consumers can also acquire these items directly through fijikava.com. Founded in 2014 and based in West End, Australia, the entity rebranded to its current name in April 2023, having previously operated as Fiji Kava Limited.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | -33.33% | -50.00% | -50.00% | -33.33% | +9.09% | -97.82% | -98.18% | -98.18% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
-
Revenue growth Packaged Foods: +4.4%+88.5% ★ Q4'25: +211.3% (vs Q4'23)
-
EPS growth Packaged Foods: +14.6%+51.5% ★ Q4'25: +130.0% (vs Q4'23)
-
FCF margin FCF growth · Packaged Foods: +15.9%-55.3% Q4'25: -28.4% (vs Q4'23)
-
EBIT margin Packaged Foods: +7.9%-44.4% Q4'25: -25.8% (vs Q4'23)
-
ROIC Packaged Foods: +7.0%-129.7% Q4'25: -133.3% (vs Q4'23)
-
Share dilution Packaged Foods: +0.0%+117.4% Q4'25: +267.0% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Packaged Foods: 0.19×-0.67× Q4'25: -1.13× (vs Q4'23)
| Metric |
Jun 2024 actual |
Jun 2025 actual |
Jun 2026 1 Rev. Ana. |
Jun 2027 1 Rev. Ana. |
Jun 2028 1 Rev. Ana. |
|---|---|---|---|---|---|
| Revenue |
4.26M
est: 4.26M (+0.1%)
|
8.03M
est: 8.00M (+0.4%)
|
10.88M
10.88M – 10.88M
+36.0% YoY
|
16.03M
16.03M – 16.03M
+47.4% YoY
|
21.14M
21.14M – 21.14M
+31.9% YoY
|
| EBITDA |
-3.34M
est: -3.59M (+6.9%)
|
-3.45M
est: -6.74M (+48.8%)
|
-9.17M
-9.17M – -9.17M
-36.0% YoY
|
-13.51M
-13.51M – -13.51M
-47.4% YoY
|
-17.81M
-17.81M – -17.81M
-31.9% YoY
|
| EBIT |
-3.55M
est: -3.64M (+2.4%)
|
-3.57M
est: -6.84M (+47.8%)
|
-9.30M
-9.30M – -9.30M
-36.0% YoY
|
-13.71M
-13.71M – -13.71M
-47.4% YoY
|
-18.08M
-18.08M – -18.08M
-31.9% YoY
|
| Net Income |
-3.73M
|
-3.99M
|
—
— – —
|
—
— – —
|
—
— – —
|
| SGA |
3.39M
est: 6.84M (-50.5%)
|
4.53M
est: 12.85M (-64.7%)
|
17.48M
17.48M – 17.48M
+36.0% YoY
|
25.75M
25.75M – 25.75M
+47.4% YoY
|
33.96M
33.96M – 33.96M
+31.9% YoY
|
| EPS |
0.00
|
0.00
|
—
— – —
|
—
— – —
|
—
— – —
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-25 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Zane Yoshida | Founder, Chief Operating Officer, MD, Chief Executive Officer & Executive Director | 272.2K | male |
| Pravinesh Lala | Chief Financial Officer | 134.2K | male |
| Natalie Climo | Company Secretary | 36.0K | female |
| Andy Burger | Head of E-Commerce | — | male |
| Matthew Kowal | Chief Commercial Officer | — | male |
| Brian Casutto | Managing Director of FijiKava Inc (USA) | — | male |
| Jerome Sarris | Member Scientific Advisory Board & Chief Scientist | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for CCO.AX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
